AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
Log in

ASX:MEMMemphasys Stock Price, Forecast & News

A$0.06
-0.01 (-14.08 %)
(As of 05/13/2020)
Add
Compare
Today's Range
A$0.06
Now: A$0.06
A$0.07
50-Day Range
A$0.06
MA: A$0.06
A$0.06
52-Week Range
A$0.03
Now: A$0.06
A$0.10
Volume246,322 shs
Average VolumeN/A
Market Capitalization$45.99 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Memphasys Limited, a bio-separations company, develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. It primarily develops Felix that separates sperm from semen sample using electrophoresis and specialist membranes for the use in fertility treatments, including IVF for humans, as well as for artificial reproductive techniques for animals; and a polymer membrane separation technology using polyacrylamide hydrogel membranes with electrophoresis. The company was formerly known as NuSep Holdings Limited and changed its name to Memphasys Limited in July 2016. Memphasys Limited is headquartered in Homebush, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.54 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 2 8415 7300

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Cash FlowA$0.01 per share
Book ValueA$0.01 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$45.99 million
Next Earnings DateN/A
OptionableNot Optionable

Receive MEM News and Ratings via Email

Sign-up to receive the latest news and ratings for MEM and its competitors with MarketBeat's FREE daily newsletter.

Memphasys (ASX:MEM) Frequently Asked Questions

Has Memphasys been receiving favorable news coverage?

Media coverage about MEM stock has been trending negative on Friday, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Memphasys earned a media sentiment score of -2.4 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the near future. View the latest news about Memphasys.

Who are some of Memphasys' key competitors?

Who are Memphasys' key executives?

Memphasys' management team includes the following people:
  • Ms. Alison Mary Coutts B.E. (Chem), GDipBiotech, MBA, Exec. Chairman & Interim CEO
  • Pablo Neyertz, Director of Fin.
  • Mr. Malcolm Coleman, Chief Financial Officer of Nusep Ltd
  • Mr. Andrew Metcalfe, Company Sec.

What is Memphasys' stock symbol?

Memphasys trades on the ASX under the ticker symbol "MEM."

What is Memphasys' stock price today?

One share of MEM stock can currently be purchased for approximately A$0.06.

How big of a company is Memphasys?

Memphasys has a market capitalization of $45.99 million.

What is Memphasys' official website?

The official website for Memphasys is www.memphasys.com.

How can I contact Memphasys?

The company can be reached via phone at 61 2 8415 7300.

This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.